Nsp3s are the largest non-structural proteins of coronaviruses. These transmembrane proteins include a papain-like protease (PLpro) that plays essential roles in cleaving viral polyproteins into their mature units. The PLpro of SARS-CoV viruses also have deubiquitinating and deISGylating activities. As Nsp3 is an endoplasmic reticulum (ER)-localized protein, we asked if the deubiquitinating activity of SARS-CoV-2 PLpro affects proteins that are substrates for ER-associated degradation (ERAD). Using full-length Nsp3 as well as a truncated transmembrane form we interrogated, by co-expression, three potential ERAD substrates, all of which play roles in regulating lipid biosynthesis. Transmembrane PLpro increased the level of INSIG-1 and decreased its ubiquitination. However, different effects were seen with SREBP-1 and SREBP-2. When co-expressed, transmembrane PLpro cleaves SREBP-1 at three sites, including two non-canonical sites in the N terminal half of the protein, resulting in a decrease in precursors of the active transcription factor. Conversely, cleavage of SREBP-2 occurs at a single canonical site that disrupts a C-terminal degron, resulting in increased SREBP-2 levels. When this site is mutated and the degron can no longer be interrupted, SREBP-2 is still stabilized by transmembrane PLpro, which correlates with a decrease in SREBP-2 ubiquitination. All of these observations are dependent on PLpro catalytic activity. Our findings demonstrate that, when anchored to the ER membrane, SARS-CoV-2 Nsp3 PLpro can function as a deubiquitinating enzyme to stabilize ERAD substrates. Additionally, SARS-CoV-2 Nsp3 PLpro can cleave ER resident proteins, including at sites that could escape analyses based on the established consensus sequence.
[doi:10.25345/C5542JK3W]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: proteolysis/deubiquitination/deubiquitinating enzyme/ubiquitin/virulence factor/COVID/virology/cholesterol/lipid biosynthesis/cell biology/mass spectrometry
|
Principal Investigators: (in alphabetical order) |
Allan M. Weissman, Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA |
| Submitting User: | sudiptodas |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|